Page 64 - 《中国药房》2022年9期
P. 64

蓝萼甲素通过Bcl-2/Beclin1靶点调节人肝癌HCCLM3细胞自噬

        与凋亡的机制研究                     Δ


        朱琳琳 ,张明明,郭格格,徐祉轩(新乡医学院医学检验学院/河南省分子检验与医学检验技术协同创新中心/河
               *
        南省免疫与靶向药物重点实验室,河南 新乡 453003)


        中图分类号 R965;R735.7          文献标志码     A      文章编号     1001-0408(2022)09-1082-06
        DOI   10.6039/j.issn.1001-0408.2022.09.10


        摘   要   目的 研究蓝萼甲素(GLA)对人肝癌HCCLM3细胞自噬与凋亡的调节作用机制。方法 HCCLM3细胞按不同实验目的主
        要设对照组、GLA 2.5 μg/mL组、GLA 5 μg/mL组、GLA 10 μg/mL组。对照组仅加入完全培养基,各给药组分别加入含GLA相应终
        质量浓度的完全培养基。采用流式细胞术检测细胞周期分布与凋亡情况;采用透射电镜观察细胞线粒体形态和自噬情况(仅设对
        照组、GLA 5 μg/mL组);采用JC-1染色和荧光倒置显微镜观察并检测细胞线粒体膜电位;采用Western blot法检测细胞中Bcl-2、
        Bax、Beclin1、活性半胱氨酸天冬氨酸蛋白酶3(cleaved caspase-3)蛋白的表达;采用免疫共沉淀法检测细胞中Bcl-2与Beclin1的结
        合与解离(仅设GLA 5 μg/mL组、GLA 10 μg/mL组)。结果 与对照组相比,GLA 5、10 μg/mL能够诱发细胞周期显著阻滞于G2~M
        期、诱导线粒体膜电位显著下降、增加促凋亡作用,还能显著促进Bax、cleaved caspase-3、Beclin1蛋白表达,显著抑制Bcl-2蛋白表
        达(P<0.01);GLA 5 μg/mL还可引发线粒体形态显著改变,自噬小体增多。免疫共沉淀法结果显示,与GLA 5 μg/mL比较,GLA
        10 μg/mL能够增强Bcl-2与Beclin1的结合。结论 GLA可能通过Bcl-2/Beclin1靶点调节HCCLM3细胞自噬与凋亡,且作用效果与
        剂量密切相关。
        关键词 蓝萼甲素;靶点;机制;自噬;凋亡;Bcl-2;Beclin1


        Study on regulation mechanism of glaucocalyxin A on the autophagy and apoptosis of HCCLM3
        hepatocellular carcinoma cells through Bcl-2/Beclin1 target
        ZHU Linlin,ZHANG Mingming,GUO Gege,XU Zhixuan(School of Laboratory Medicine,Xinxiang Medical
        University/Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine/Henan Key
        Laboratory of Immunology and Targeted Therapy,Henan Xinxiang 453003,China)


        ABSTRACT    OBJECTIVE To study the regulatory mechanism of glaucocalyxin A (GLA) on autophagy and apoptosis of
        HCCLM3 hepatocellular carcinoma cells. METHODS HCCLM3 cells were taken,and control group,GLA 2.5 μg/mL group,GLA
        5 μg/mL group and GLA 10 μg/mL group were mainly set according to different experimental purposes. In control group,only
        complete medium was added;in each administration group,complete medium containing the corresponding final concentration of
        GLA was added. Cell cycle distribution and apoptosis were detected by flow cytometry;mitochondrial morphology and autophagy
        were observed by transmission electron microscope(only control group,GLA 5 μg/mL group);JC-1 staining and fluorescence
        inverted microscope were used to observe and detect the mitochondrial membrane potential of the cells;Western blot assay was
        used to detect the protein expression of Bcl-2, Bax, Beclin1 and cleaved caspase-3 proteins in the cells; the
        co-immunoprecipitation method was used to detect the binding and dissociation of Bcl-2 and Beclin1(only GLA 5 μg/mL group,
        GLA 10 μg/mL group). RESULTS Compared with control group,GLA 5 μg/mL and GLA 10 μg/mL could induce a significant
        arrest of the cell cycle in the G2-M phase for HCCLM3,a significant decrease in mitochondrial membrane potential,an increase in
        apoptosis as well as significant promotion of the protein expression of Bax,cleaved caspase-3 and Beclin1,and significant
        inhibition of the protein expression of Bcl-2(P<0.01). GLA 5 μg/mL also significantly changed mitochondrial morphology and
        increased autophagosomes. The results of co-immunoprecipitation showed that compared with GLA 5 μg/mL,GLA 10 μg/mL could
        enhance the binding of Bcl-2 and Beclin1. CONCLUSIONS GLA can regulate the autophagy and apoptosis of HCCLM3 cells by
        Bcl-2/Beclin1 target. The effect is closely related to the dose of GLA.
        KEYWORDS     glaucocalyxin A;target;mechanism;autophagy;apoptosis;Bcl-2;Beclin1


                                                                细胞自噬与凋亡存在诸多联系,与一系列基因激
            Δ 基金项目:河南省科技攻关项目(No.212102310753)
                                                            活、表达调控相关。正常情况下,两者处于平衡状态;药
            *副教授,博士。研究方向:中草药抗肿瘤作用机制。电话:
        0373-3832181。E-mail:linbetter@163.com               物、环境可以打破二者平衡,引发细胞走向不同结局,从


        ·1082 ·  China Pharmacy 2022 Vol. 33 No. 9                                   中国药房    2022年第33卷第9期
   59   60   61   62   63   64   65   66   67   68   69